Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves

Glower, Donald D.; Landolfo, Kevin P.; Cheruvu, Srinivas; Cen, Ye-Ying; Harrison, J. Kevin; Bashore, Thomas M.; Smith, Peter K.; Jones, Robert H.; Wolfe, Walter G.; Lowe, James E.

doi:10.1016/s0003-4975(98)01114-x

Cited by 61 publications

(29 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of publications document the risk assessment for re-replacement for aortic prosthetic dysfunction. 6,9,11,13 The publications addressing bioprosthetic valve failure are Akins, 1 Bortollotti, 2 Glower, 7 McGiffin, 9 O'Brien, 14 Sundt, 12 Vogt, 6 and Jamieson 13 and colleagues. The publications by Tyers, 3 McGrath, 4 and Sener 5 and their colleagues access both bioprostheses and mechanical prostheses and the publications address re-replacement risk for mitral bioprosthetic structural valve deterioration.…”

Section: Discussionmentioning

confidence: 99%

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

et al. 2003

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

et al. 2003

View full text Add to dashboard Cite

show abstract

“…Chronically, IS risk of MRep is low and antithrombotic treatment should be individualized (37). In older patients with MVRb and faster endothelial restoration (43,44), no excess embolic risk is noted Ͼ30 days and prolonged anticoagulation is of dubious benefit (45).…”

Section: Long-term Thromboembolic and Hemorrhagic Complications A CLmentioning

confidence: 99%

Thromboembolic Complications After Surgical Correction of Mitral Regurgitation

Russo

Grigioni

Avierinos

et al. 2008

Journal of the American College of Cardiology

130

View full text Add to dashboard Cite

Thromboembolic complications after MR surgery are a reason for both concern and encouragement. The risk of IS is notable early, irrespective of procedure, but in the long term it is not greater than in the population after MRep and MVRb. Preference for MRep should be emphasized, and trials aiming at preventing IS should be conducted to reduce thromboembolic and hemorrhagic risk after surgery for MR.

show abstract

“…Therefore, early or late degeneration of bioprosthetic heart valves (BHV) resulting in stenosis, regurgitation, or combined failure and requiring reoperation is an increasing issue. In a long term follow up study of 1119 patients Glower et al reported incidence of reoperation for failing BHV of 5%, 10%, and 30% at 5, 10, and 15 years, respectively. Redo surgery in older patients with comorbidities for degenerated SHV is associated with a higher mortality and morbidity.…”

Section: Introductionmentioning

confidence: 99%